Oghuzan Atay, co-founder and CEO of BillionToOne

Pre­ci­sion di­ag­nos­tics biotech wins newest round of in­vestor back­ing in bid to fa­cil­i­tate com­pa­ny ex­pan­sion

Di­ag­nos­tics firm Bil­lion­ToOne raised $55 mil­lion in a Se­ries B last year in a bid to ex­pand the com­pa­ny, which mar­kets a pre­na­tal screen­ing test …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.